Baseline predictors of antibiotics de-escalation from empirical therapies in an intensive care unit: a five-year retrospective study.

IF 3.4 3区 医学 Q2 INFECTIOUS DISEASES
Ann Lisa Arulappen, Amer Hayat Khan, Monica Danial, Syed Shahzad Hasan, Ting Soo Chow, Nehad Jaser Ahmed, Chiau Ming Long
{"title":"Baseline predictors of antibiotics de-escalation from empirical therapies in an intensive care unit: a five-year retrospective study.","authors":"Ann Lisa Arulappen, Amer Hayat Khan, Monica Danial, Syed Shahzad Hasan, Ting Soo Chow, Nehad Jaser Ahmed, Chiau Ming Long","doi":"10.1186/s12879-025-10752-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The alarming rate of bacterial resistance has urged for vigorous antibiotic de-escalation cultures worldwide. However, the art of de-escalation remains challenging as most clinicians have the fear or stigma that antibiotic de-escalation is strongly associated with higher mortality. This study aimed to determine the factors strongly correlated with higher mortality rates after antibiotic de-escalation and possibly serve as a benchmark study for developing a validated antibiotic de-escalation tool in the near future.</p><p><strong>Method: </strong>This retrospective study was conducted on patients hospitalized in a medical intensive care unit of a referral tertiary care center and subjected to antibiotics de-escalation over five years. Independent factors associated with mortality post antibiotics de-escalation were assessed. Various data were collected, including patient demographics, admission and discharge dates, a primary source of infection and free of infection status, choices of antibiotic used and de-escalation history, vital signs, data on X-ray changes, relevant laboratory investigations, microbiological culture history, mortality status, history of COVID-19 infection, presence of central line, number of vasopressors used, ventilator settings and respective SOFA scores.</p><p><strong>Results: </strong>Prevalence of mortality among patients continued on broad-spectrum antibiotics empirically is remarkable. Through this study, it was found that the significant factors associated with mortality post antibiotic de-escalation were hospital-acquired infection (HAI) (Adjusted OR: 12.56; 95% CI: 2.88,54.98; p < 0.001), systolic blood pressure in mmHg (Adjusted OR: 0.08; 95% CI: 0.02,0.33; p < 0.001), heart rate in bpm (Adjusted OR: 0.12; 95% CI: 0.03,0.45; p:0.002), SOFA scores (Adjusted OR: 21.44; 95% CI: 3.55,129.52; p:0.001) and number of vasopressors (Adjusted OR: 38.46; 95% CI: 1.54,959.30; p:0.026).</p><p><strong>Conclusion: </strong>De-escalation of antibiotics is considerable as the identified significant factors serve as baseline predictors which would certainly be helpful especially during the decision-making process of antibiotic de-escalation among the clinicians. Therefore, antibiotics de-escalation is highly encouraged to reduce the mortality risks.</p>","PeriodicalId":8981,"journal":{"name":"BMC Infectious Diseases","volume":"25 1","pages":"369"},"PeriodicalIF":3.4000,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11912597/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12879-025-10752-6","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The alarming rate of bacterial resistance has urged for vigorous antibiotic de-escalation cultures worldwide. However, the art of de-escalation remains challenging as most clinicians have the fear or stigma that antibiotic de-escalation is strongly associated with higher mortality. This study aimed to determine the factors strongly correlated with higher mortality rates after antibiotic de-escalation and possibly serve as a benchmark study for developing a validated antibiotic de-escalation tool in the near future.

Method: This retrospective study was conducted on patients hospitalized in a medical intensive care unit of a referral tertiary care center and subjected to antibiotics de-escalation over five years. Independent factors associated with mortality post antibiotics de-escalation were assessed. Various data were collected, including patient demographics, admission and discharge dates, a primary source of infection and free of infection status, choices of antibiotic used and de-escalation history, vital signs, data on X-ray changes, relevant laboratory investigations, microbiological culture history, mortality status, history of COVID-19 infection, presence of central line, number of vasopressors used, ventilator settings and respective SOFA scores.

Results: Prevalence of mortality among patients continued on broad-spectrum antibiotics empirically is remarkable. Through this study, it was found that the significant factors associated with mortality post antibiotic de-escalation were hospital-acquired infection (HAI) (Adjusted OR: 12.56; 95% CI: 2.88,54.98; p < 0.001), systolic blood pressure in mmHg (Adjusted OR: 0.08; 95% CI: 0.02,0.33; p < 0.001), heart rate in bpm (Adjusted OR: 0.12; 95% CI: 0.03,0.45; p:0.002), SOFA scores (Adjusted OR: 21.44; 95% CI: 3.55,129.52; p:0.001) and number of vasopressors (Adjusted OR: 38.46; 95% CI: 1.54,959.30; p:0.026).

Conclusion: De-escalation of antibiotics is considerable as the identified significant factors serve as baseline predictors which would certainly be helpful especially during the decision-making process of antibiotic de-escalation among the clinicians. Therefore, antibiotics de-escalation is highly encouraged to reduce the mortality risks.

求助全文
约1分钟内获得全文 求助全文
来源期刊
BMC Infectious Diseases
BMC Infectious Diseases 医学-传染病学
CiteScore
6.50
自引率
0.00%
发文量
860
审稿时长
3.3 months
期刊介绍: BMC Infectious Diseases is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of infectious and sexually transmitted diseases in humans, as well as related molecular genetics, pathophysiology, and epidemiology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信